Probiotic Intervention for Stress and Cognition
A Randomized, Double-blinded, Placebo-controlled, Parallel Clinical Trial of a Probiotic on Stress and Cognitive Function in Healthy Adults
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cork, Ireland
- Atlantia Food Clinical Trials
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Willing to participate in the study and comply with its procedures.
- Be able to give written informed consent.
- Be between 21 and 50 years.
- Have moderate stress, as measured on Cohen's Perceived Stress Scale (PSS).
- Are not suffering from depression or anxiety, confirmed by a Hospital Anxiety and Depression Scale (HADS) score.
- Are not regularly consuming probiotics for at least 4 weeks prior to the Screening Visit.
- Is in general good health, as determined by the investigator.
Exclusion Criteria:
- Current diagnosis of currently active irritable bowel syndrome (IBS), according to Rome IV criteria.
- Chronic intestinal disease, immunodeficiency disorder or immunosuppressive treatment.
- Known gluten intolerance, lactose intolerance, milk protein allergy.
- Intake of antibiotics within four weeks prior to the Screening Visit.
- Hypersensitivity to any of the ingredients in the Investigational Product (IP).
- Previous (within 5 years) or ongoing psychiatric illness.
- Consumption of systemic psychotropics, rheumatoid drugs, steroid drugs or creams containing cortisone.
- Regular consumption of asthma medications.
- History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk if participating in the study, or influence the results or the participant´s ability to participate in the study.
- Investigator considers the participant unlikely to comply with study procedures, restrictions, and requirements.
- Any disease, that by the investigator's judgement, could interfere with the intestinal barrier function.
- Participation in other clinical trials involving Investigational Product consumption in the last month.
- Desire and/or plans on changing current diet and/or exercise regime during the participation of this trial.
- Participants who are pregnant, breastfeeding, or wish to become pregnant during the study.
- Participants currently of childbearing potential, but not using an effective method of contraception.
- Have a malignant disease or any concomitant end-stage organ disease, which, in the Investigator's judgment, contraindicates participation in the study.
- Individuals who, in the opinion of the investigator, are considered to be poor clinical attendees or unlikely for any reason to be able to comply with the trial.
- Taking any supplements or vitamins notably known to affect cognitive function. Vitamin D and calcium supplements permitted if on a stable dose for the previous 3 months.
- History of heavy caffeinated beverage consumption (>400 mg caffeine/day) within past 2 weeks prior to the Screening Visit.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Probiotics
One capsule per day for 12 weeks
|
Capsule
|
|
Placebo Comparator: Placebo
One capsule per day for 12 weeks
|
Capsule
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine whether intake of probiotics reduce perceived stress
Time Frame: 12 weeks
|
Perceived stress will be evaluated with Cohen's Perceived Stress Scale (PSS) (min 0, max 40)
|
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- AFCRO-136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.